SLI
2.019,59
PKT
+11,20
PKT
+0,56
%
Werbung
Analysen zu SLI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
13.12.16 | Swiss Re buy | Deutsche Bank AG | |
13.12.16 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
13.12.16 | ABB (Asea Brown Boveri) Underperform | Jefferies & Company Inc. | |
13.12.16 | Novartis buy | HSBC | |
13.12.16 | Zurich Insurance Outperform | Credit Suisse Group | |
12.12.16 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
12.12.16 | Zurich Insurance overweight | Barclays Capital | |
12.12.16 | Swiss Re Underweight | Barclays Capital | |
12.12.16 | UBS overweight | JP Morgan Chase & Co. | |
12.12.16 | UBS Neutral | JP Morgan Chase & Co. | |
12.12.16 | Swiss Re Underperform | Credit Suisse Group | |
09.12.16 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
09.12.16 | UBS buy | HSBC | |
09.12.16 | Holcim buy | Deutsche Bank AG | |
09.12.16 | UBS Hold | Deutsche Bank AG | |
09.12.16 | UBS buy | UBS AG | |
08.12.16 | Zurich Insurance Hold | Jefferies & Company Inc. | |
08.12.16 | UBS overweight | JP Morgan Chase & Co. | |
08.12.16 | Swiss Re Underperform | Jefferies & Company Inc. | |
08.12.16 | Swiss Re buy | Deutsche Bank AG | |
08.12.16 | UBS buy | Kepler Cheuvreux | |
08.12.16 | UBS neutral | Morgan Stanley | |
08.12.16 | Zurich Insurance buy | HSBC | |
08.12.16 | Roche buy | UBS AG | |
08.12.16 | Novartis Neutral | UBS AG | |
08.12.16 | UBS Sell | S&P Capital IQ | |
08.12.16 | UBS buy | Goldman Sachs Group Inc. | |
07.12.16 | Swiss Re Outperform | Robert W. Baird & Co. Incorporated | |
07.12.16 | Zurich Insurance neutral | Robert W. Baird & Co. Incorporated | |
07.12.16 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
07.12.16 | Roche buy | Deutsche Bank AG | |
07.12.16 | Holcim Neutral | JP Morgan Chase & Co. | |
07.12.16 | Givaudan overweight | JP Morgan Chase & Co. | |
07.12.16 | Nestlé overweight | JP Morgan Chase & Co. | |
07.12.16 | Swiss Re Underperform | BNP PARIBAS | |
06.12.16 | Swiss Re Hold | Baader Bank | |
06.12.16 | UBS Equal weight | Morgan Stanley | |
06.12.16 | UBS overweight | Morgan Stanley | |
06.12.16 | Roche overweight | JP Morgan Chase & Co. | |
06.12.16 | Swiss Re Neutral | Goldman Sachs Group Inc. |